Skip to main content
Skip to main content
Go to homepage

Classification of Newly Diagnosed Acute Lymphoblastic Leukemia (ALL)

Risk-Based Classification of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia (ALL)

Description:

For complete study information, please visit clinicaltrials.gov.

Study Status:
Closed
IRB Study ID:
100904
If you are interested in this study or have questions about your child's eligibility, please contact:
Rebecca D. Considine Research Institute, 330-543-3193 or email research@akronchildrens.org
Lead Investigator
Steven Kuerbitz, MD

Director, Divisional Research, Shannon E. Wilkes Targeted Therapy Program; The Jeffrey A. Barbour Chair for Pediatric Hematology/Oncology Research and Healing; Pediatric Hematologist-Oncologist
Showers Family Center for Childhood Cancer and Blood DisordersPediatric Stem Cell Transplant Program

By using this site, you consent to our use of cookies. To learn more, read our privacy policy.